Product Information

FT INF IBUPROFEN 50 MG/1.25 ML is a generic product labeled by Strategic Sourcing Services LLC, priced at $0.3120 per ML under NDC 70677114401. Its NADAC has been published 99 times since Oct 2, 2024.

FDA first approved this application on Dec 16, 1998.

The High Outlier badge above means this manufacturer's average price in the ibuprofen market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

FT INF IBUPROFEN 50 MG/1.25 ML

ibuprofen
$0.3120per ML
High Outlier
OTC

Strength

50 mg/1.25mL

NDC

70677114401

Classification

Generic

Dosage Form

SUSPENSION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

IBUPROFEN

Approval Type

Generic (ANDA)

FDA Application

ANDA075217

FDA Approved

12/16/1998

On Market Since

7/12/2024

Pharmacological Classes

Anti-Inflammatory Agents
Non-Steroidal
Cyclooxygenase Inhibitors
Nonsteroidal Anti-inflammatory Drug

Price Statistics

The NADAC for FT INF IBUPROFEN 50 MG/1.25 ML has been published 99 times since Oct 2, 2024, and over the history we have for it it has risen 11.2%. The table below summarizes its recorded NADAC range and movement.

Current price$0.3120 per ML
All-time high$0.3307 (Jun 10, 2026)
All-time low$0.2783 (Oct 23, 2024)
52-week high$0.3307
52-week low$0.3050
Median price$0.3084
Average price$0.3066
Largest weekly change+6.4% (Apr 22, 2026)
Weeks tracked99
Tracking sinceOct 2, 2024

Price History

1W

+1.6%

1M

+1.6%

3M

-5.7%

6M

+2.3%

1Y

-3.3%

3Y

N/A

5Y

N/A

All

+11.2%

Generic Alternatives

The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 25% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.

Frequently asked questions

What is the NADAC price of FT INF IBUPROFEN 50 MG/1.25 ML?

The current National Average Drug Acquisition Cost (NADAC) for FT INF IBUPROFEN 50 MG/1.25 ML, manufactured by Strategic Sourcing Services LLC, is $0.3120 per ML (NDC 70677114401), effective Aug 19, 2026.

How has the price of FT INF IBUPROFEN 50 MG/1.25 ML changed over time?

Over the history we have for it, the NADAC for FT INF IBUPROFEN 50 MG/1.25 ML has risen 11.2%. It has been tracked across 99 weekly CMS publications since Oct 2, 2024.

What are the highest and lowest recorded NADAC prices for FT INF IBUPROFEN 50 MG/1.25 ML?

Since Oct 2, 2024, the NADAC for FT INF IBUPROFEN 50 MG/1.25 ML has ranged from a low of $0.2783 (Oct 23, 2024) to a high of $0.3307 (Jun 10, 2026), with a median of $0.3084 per ML.

Are there cheaper alternatives to FT INF IBUPROFEN 50 MG/1.25 ML?

Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, INFANT IBUPROFEN 50 MG/1.25 ML, is $0.2324 per ML — about 25% below FT INF IBUPROFEN 50 MG/1.25 ML.

Who manufactures FT INF IBUPROFEN 50 MG/1.25 ML?

FT INF IBUPROFEN 50 MG/1.25 ML (NDC 70677114401) is labeled by Strategic Sourcing Services LLC, and CMS classifies it as a generic product.